Atlas Trials

Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma

Clinical trial NCT06220032 · RECRUITING

Trial details

NCT number
NCT06220032
Sponsor
Stichting Hemato-Oncologie voor Volwassenen Nederland
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
DLBCL - Diffuse Large B Cell Lymphoma
Start date
2024-08-15
Primary completion
2028-12-15
Enrollment
324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.